Pharmaceutical Manufacturers Association: Key Facts about the U.S. Prescription Drug and Medical Device Industries.
3.
SchwartzmanD.: Innovation in the Pharmaceutical Industry, Johns Hopkins University Press, Baltimore, 1976.
4.
SmithM.C.: Principles of Pharmaceutical Marketing, Lea & Febiger, Philadelphia, 1968.
5.
Annual Survey of Manufacturers, Industry Profiles, 1976.
6.
LindsayC. M., ed: The Pharmaceutical Industry: Economics, Performance and Government Regulation, John Wiley & Sons, New York, 1978.
7.
SchwartzmanD.: The Expected Return from Pharmaceutical Research, American Enterprise Institute for Public Policy Research, Washington, D.C., 1975.
8.
Drug Industry, Drug Research Quarterly, Kidder, Peabody & Co., Sept. 21, 1978.
9.
WardellW. M.LasagnaL.: Regulation and Drug Development, American Enterprise Institute for Public Policy Research, Washington, D.C., 1975.
10.
CooperJ. D., ed: The Economics of Drug Innovation, The American University, Washington, D.C., 1970.
11.
WardellW. M.: The drug lag revisited: Comparison by therapeutic area of patterns of drugs marketed in the United States and Great Britain from 1972 through 1976, Clin. Pharmacol. Ther. 24:499–524, 1978.
12.
PeltzmanS.: Regulation of Pharmaceutical Innovation, American Enterprise Institute for Public Policy Research, Washington, D.C., 1974.
13.
GrabowskiH. G.: The effects of substitution laws on innovation. Drug Ther., Dec. 1978.